Focused Research Award – HT942524ATRPFRA
- Research Level 1 – up to USD$500,000 over 2 years – supports exploratory, high-risk, high-reward research or
- Research Level 2 – up to USD$750,000 over 3 years – supports advancement of pre-clinical research toward clinical translation
- Letters of intent due 16 October 2024
- supports conceptually innovative, high-risk/potentially high-reward research that could ultimately lead to critical discoveries and/or improvement in patient care or quality of life for people impacted by arthritis
- clinical research and clinical trials not allowed
- preliminary and/or published data required
- must address at least one of the following focus areas: Prevention; Diagnosis and Progression Mitigation; or Intervention/Treatment
- Document – Funding Opportunity: HT9425FY24ATRPFRA_GG
Clinical Research Award – HT942524ATRPCRA
- Up to USD$1.5M over 4 years or up to USD$3M over 4 years for Clinical Trial Option
- Letters of intent due 16 October 2024
- supports clinical research that evaluates disease-specific factors and interventions; generating clinically useful evidence with potential to optimise patient outcomes and inform clinical care or policy
- pre-clinical and animal research is not allowed
- preliminary and/or published data required
- must address at least one of the following focus areas: Prevention; Diagnosis and Progression Mitigation; or Intervention/Treatment
- Document – Funding Opportunity: HT9425FY24ATRPCRA_GG
